Navigation Links
Ceramide can target and kill cancer cells,,

Research by the scientists from Penn State College of Medicine brought to light that injecting ceramide// into the blood stream it is possible to target and kill breast cancer cells.

Ceramide is a natural substance that accumulates in the cancer cells and thus may be used to get better results out of breast cancer treatments. Researchers had used their techniques on mice for successful results.

However injecting ceramide in the usual way into the blood stream can have severe toxic results. Scientists, to overcome this, have used nanotechnology to create capsules of ceramides called liposomes. Such a way makes it easy for the capsules to move in the blood stream and release the ceramides in the tumor cells. This happens as ceramides are, by nature still unknown to scientists, attracted to tumor cells.

The liposome-encased ceramides reaches the tumor cells via the bloodstream. Then it enters the tumor cells through the vasculature, and disrupts the mitochondria of the cells. In mice these bundles of ceramide targets and destroys only breast cancer cells, leaving the surrounding cells healthy and functional.

The results of the study came up in the new issue of the journal Clinical Cancer Research.

Reference: Penn State University, Press Release, May 2005
'"/>




Page: 1

Related medicine news :

1. Ceramide Directs Stem Cells in Embryo
2. Feeding channel created by malaria parasite - a new target for malaria treatments
3. Enzyme may be target for obesity drugs
4. Scios Inc. targets drug giants in arthritis war
5. Pharmaceutical companies are targeting patients
6. New target for antidiabetic agents identified
7. Multi targeted approach required for suicide prevention in adolescents
8. GPs discontented with 48-hour target
9. Maori diabetes project way off target
10. Microcapsules target cancer cells
11. Indian American Scientist at Work on Multi-targeted Drug
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/27/2017)... ... July 27, 2017 , ... Standard Process is ushering in a new era ... North Carolina Research Campus (NCRC) in Kannapolis, North Carolina and by announcing a new ... fall of this year, occupying over 10,000 square feet on the first floor of ...
(Date:7/27/2017)... ... 2017 , ... For bicycling enthusiasts around the globe, Germany's famous Rad am ... against a backdrop of tree-lined hills at the Nürburgring, a Formula One arena known ... Ring consists of some 73 curves, stretching out over more than 500 meters of ...
(Date:7/27/2017)... (PRWEB) , ... July 28, 2017 , ... ... Syngenta on an upcoming episode of the award-winning television series, American Famer, scheduled ... on RFD-TV. , Syngenta is dedicated to helping humanity face its toughest ...
(Date:7/27/2017)... OH (PRWEB) , ... July 27, 2017 , ... ... Electronic Visit Verification to State Medicaid programs, Managed Care Organizations and Home Care ... 2017. , The MEDsys platform, VinCENT, provides technology solutions to over 1,000 agencies ...
(Date:7/27/2017)... ... 2017 , ... GAFFEY Healthcare, a leading provider of revenue ... Vice President of Revenue Cycle Business Services and Suzanne Dusak to Vice President ... officer (CEO). , Elrene has been with company since Oct 2014 and previously ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... 2017 Zymo Research Corp., also known as ,The Epigenetics Company, ... aging in a precise manner using the myDNAge ™ test. Based ... professor of human genetics and biostatistics at the David Geffen School ... , Zymo Research,s proprietary DNAge ™ technology is used to analyze ... ...
(Date:7/11/2017)... JERUSALEM , July 11, 2017 Oramed ... ), a clinical-stage pharmaceutical company focused on the development ... U.S. Food and Drug Administration (FDA) has agreed to ... successfully completed Phase IIb trial of its oral insulin ... The Phase IIb trial met primary and secondary endpoints ...
(Date:7/10/2017)... , July 10, 2017 Locus Biosciences ... Note to support the development of CRISPR-Cas3 antimicrobial therapeutics. ... Limited, a leading Chinese Internet services provider, and joined ... advance multiple infectious disease product programs targeting antibiotic resistant ... Founded by Dr. Rodolphe Barrangou ...
Breaking Medicine Technology: